Pharmacological preconditioning of mesenchymal stem cells with trimetazidine (1-[2,3,4-trimethoxybenzyl]piperazine) protects hypoxic cells against oxidative stress and enhances recovery of myocardial function in infarcted heart through Bcl-2 express (Q43141698)
Jump to navigation
Jump to search
scientific article published on 13 February 2009
Language | Label | Description | Also known as |
---|---|---|---|
English | Pharmacological preconditioning of mesenchymal stem cells with trimetazidine (1-[2,3,4-trimethoxybenzyl]piperazine) protects hypoxic cells against oxidative stress and enhances recovery of myocardial function in infarcted heart through Bcl-2 express |
scientific article published on 13 February 2009 |
Statements
Pharmacological preconditioning of mesenchymal stem cells with trimetazidine (1-[2,3,4-trimethoxybenzyl]piperazine) protects hypoxic cells against oxidative stress and enhances recovery of myocardial function in infarcted heart through Bcl-2 expression (English)
Sheik Wisel
M Lakshmi Kuppusamy
I Krishna Mohan
Simi M Chacko
Brian K Rivera
Benjamin C Sun
Kálmán Hideg
Periannan Kuppusamy
13 February 2009
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference